新型冠状病毒感染(COVID-19) 可造成骨骼肌质量和功能的改变, 导致急性肌肉减少症的发生.
急性肌肉减少症对COVID-19 的治疗和康复也会产生不利影响, 它们之间可形成恶性循环 …

The COVID-19 pandemic has had a devastating global impact, with older adults being most
at risk of death from the disease. However, acute sarcopenia occurs in survivors of COVID …

COVID-19 can manifest as either asymptomatic or progressing to a severe phase in some
patients, which may require hospitalization. These patients may experience dyspnea and …

Background Chronic disease causes skeletal muscle loss that contributes to morbidity and
mortality. There are limited data on the impact of dynamic muscle loss on clinical outcomes …

Aim: We designed this study with the intention of determining the prevalence of sarcopenia
and the association between sarcopenia findings and the severity of COVID-19 disease in …

Although the paper possessed convincing evidences, several issues still need to be
addressed. Firstly, Morley et al. mentioned that the angiotensin‐converting enzyme 2 …

Background. The COVID‐19 pandemic is an extraordinary global emergency. The pandemic
has changed profoundly people's lifestyles. This resulted in reductions in physical activity …

As the world comes into terms with the persistent existence of the coronavirus disease 19
(COVID-19) pandemic, the scientific and medical communities have started shifting their …

Background: Coronavirus disease 2019 (Covid-19) is an emerging disease that causes
severe complications in subjects with risk factors: advanced age, diabetes, hypertension …

Objectives: To investigate whether sarcopenia had an effect on in-hospital mortality
independent from other demographic characteristics in patients with Coronavirus disease …